NCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
AVM Biotechnology Inc
University of California, San Francisco
Servier
Day One Biopharmaceuticals, Inc.
University of California, San Francisco
Seagen Inc.